Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The magic and mystery of miR-21
Edward E. Morrisey
Edward E. Morrisey
Published October 18, 2010
Citation Information: J Clin Invest. 2010;120(11):3817-3819. https://doi.org/10.1172/JCI44596.
View: Text | PDF
Commentary

The magic and mystery of miR-21

  • Text
  • PDF
Abstract

MicroRNAs (miRNAs) are potent regulators of mRNA stability and thereby protein expression. As such, miRNAs have become of interest as possible therapeutics and/or therapeutic targets. In this context, small complementary miRNA sequences known as antagomirs could be used to inhibit miRNA activity, while miRNA mimics could confer gain-of-function activity. However, a note of caution is sounded by Patrick et al. in this issue of the JCI, as they show that although recent reports have suggested that an miR-21 antagomir might be therapeutically useful in preventing heart failure in mice, genetic deletion of miR-21 does not confer a similar phenotype, suggesting possible confounding factors that are only now beginning to be revealed in the techniques used to study miRNA biology.

Authors

Edward E. Morrisey

×

Total citations by year

Year: 2025 2023 2021 2020 2019 2018 2017 2016 2014 2013 2012 2011 2009 Total
Citations: 1 1 1 1 1 1 1 2 2 4 6 1 1 23
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (23)

Title and authors Publication Year
Vertical growth of rhenium disulfide on rGO empowers multi-signal amplification for ultrasensitive MiRNA-21 detection.
Ouyang R, Huang Y, Chen H, Ma Y, Ye T, Liu X, Wang Y, Zhao Y, Jiang Y, Miao Y, Liu B
Mikrochimica acta 2025
Is miR-21 A Therapeutic Target in Cardiovascular Disease?
Holland A, Enrick M, Diaz A, Yin L
2023
Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis
MC de Sousa, N Calo, C Sobolewski, M Gjorgjieva, S Clément, C Maeder, D Dolicka, M Fournier, L Vinet, X Montet, JF Dufour, B Humar, F Negro, C Sempoux, M Foti
Cancers 2021
Genetic Ablation of MiR-22 Fosters Diet-Induced Obesity and NAFLD Development
M Gjorgjieva, C Sobolewski, AS Ay, D Abegg, MC de Sousa, D Portius, F Berthou, M Fournier, C Maeder, P Rantakari, FP Zhang, M Poutanen, D Picard, X Montet, S Nef, A Adibekian, M Foti
Journal of Personalized Medicine 2020
The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke
E Heydari, M Alishahi, F Ghaedrahmati, W Winlow, SE Khoshnam, A Anbiyaiee
Metabolic Brain Disease 2019
miRNA miR-21 Is Largely Dispensable for Intrathymic T-Cell Development
H Kunze-Schumacher, SJ Winter, E Imelmann, A Krueger
Frontiers in immunology 2018
Emerging Roles of microRNAs in Ischemic Stroke: As Possible Therapeutic Agents
SE Khoshnam, W Winlow, Y Farbood, HF Moghaddam, M Farzaneh
Journal of Stroke 2017
A reciprocal thyroid hormone-microRNA21 interplay regulates Hedgehog pathway-driven skin tumorigenesis
Daniela Di Girolamo, Ambrosio Raffaele, Maria Angela De Stefano, Giuseppina Mancino, Tommaso Porcelli, Cristina Luongo, Emery Di Cicco, Giulia Scalia, Luigi Del Vecchio, Annamaria Colao, Andrzej Dlugosz, Caterina Missero, Domenico Salvatore, Monica Dentice
Journal of Clinical Investigation 2016
Epigenetic associations in relation to cardiovascular prevention and therapeutics
S Voelter-Mahlknecht
Clinical Epigenetics 2016
MiRNA inhibition in tissue engineering and regenerative medicine
KR Beavers, CE Nelson, CL Duvall
Advanced Drug Delivery Reviews 2014
MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2
Q Ruan, P Wang, T Wang, J Qi, M Wei, S Wang, T Fan, D Johnson, X Wan, W Shi, H Sun, YH Chen
Cell Death and Disease 2014
Using microRNA as an Alternative Treatment for Hyperlipidemia and Cardiovascular Disease: cardio-miRs in the Pipeline
EJ Hennessy, KJ Moore
Journal of Cardiovascular Pharmacology 2013
MiR-193b and miR-365-1 are not required for the development and function of brown fat in the mouse
Y Feuermann, K Kang, O Gavrilova, N Haetscher, SJ Jang, KH Yoo, C Jiang, FJ Gonzalez, GW Robinson, L Hennighausen
RNA biology 2013
Approaches to manipulating microRNAs in neurogenesis
H Zhang, B Shykind, T Sun
Frontiers in neuroscience 2013
Expression and prognostic value of Ars2 in hepatocellular carcinoma
Q He, Y Huang, L Cai, S Zhang, C Zhang
International Journal of Clinical Oncology 2013
Holding our breath: The emerging and anticipated roles of microRNA in pulmonary hypertension
K White, J Loscalzo, SY Chan
Pulmonary circulation 2012
KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts
Z Qin, A Jakymiw, V Findlay, C Parsons
International Journal of Cell Biology 2012
Hypoxamirs in Pulmonary Hypertension: Breathing New Life into Pulmonary Vascular Research
AE Hale, K White, SY Chan
Cardiovascular diagnosis and therapy 2012
The Expression of microRNA and microRNA Clusters in the Aging Heart
X Zhang, G Azhar, JY Wei
PloS one 2012
A Novel Molecular Signature for Elevated Tricuspid Regurgitation Velocity in Sickle Cell Disease
AA Desai, T Zhou, H Ahmad, W Zhang, W Mu, S Trevino, MS Wade, N Raghavachari, GJ Kato, MH Peters-Lawrence, T Thiruvoipati, K Turner, N Artz, Y Huang, AR Patel, JX Yuan, VR Gordeuk, RM Lang, JG Garcia, RF Machado
American journal of respiratory and critical care medicine 2012
MicroRNA 21 in tissue injury and inflammation
Sen CK, Roy S
Cardiovascular Research 2012
Shielding the messenger (RNA): microRNA-based anticancer therapies
E Sotillo, A Thomas-Tikhonenko
Pharmacology & Therapeutics 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts